Our results demonstrated that inhibitors of CXCL8 significantly decreased the progression of ovarian cancer cells, indicating that the development of chemokine inhibitors may effectively suppress the progression of ovarian cancer. Here, CXCL8 is linked to ovarian carcinoma.